关于慢性阻塞性肺病药理治疗的最新情况
Madeleine R Jacques1, Brooks T Kuhn1,2,3, Timothy E Albertson1,2,3
1Department of Internal Medicine, UC Davis School of Medicine, Sacramento, CA, USA.
最近的进展为慢性阻塞性肺病 (COPD) 提供了新的治疗方法,但个性化医疗是关键. 确定患者的内型和表型指导复杂的药物治疗,以更好地治疗COPD.
科学领域:
- 肺部医学 肺部医学
- 药物治疗 药物治疗
- 呼吸系统疾病 呼吸系统疾病
背景情况:
- 慢性阻塞性肺病 (COPD) 是一种普遍存在的呼吸道疾病,与环境因素和遗传学有关.
- 最近的突破为管理COPD患者引入了新的治疗策略.
研究的目的:
- 审查目前和新兴的COPD治疗方法.
- 强调个性化医疗在COPD药物治疗中的重要性.
主要方法:
- 关于支气管扩展剂,皮质类固醇,PDE抑制剂,抗生素和生物制剂的最新数据的文献综述.
- 基于COPD内型和表型的针对性治疗方法的讨论.
主要成果:
- 新的药理选择包括新型支气管扩展剂,向性皮质类固醇使用,PDE抑制剂 (如恩西芬林) 和选择性抗生素.
- 生物制剂,如dupilumab,对COPD患者具有喘-COPD重叠和特定的炎症概况有希望.
结论:
- 随着COPD治疗的不断变化,需要采用更复杂,更个性化的方法.
- 识别特定的内型和表型对于优化昂贵的药物治疗和改善患者结果至关重要.
更多相关视频
05:34Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
Published on: August 18, 2023
05:19Author Spotlight: An Effective Traditional Chinese Medicinal Treatment for Chronic Obstructive Pulmonary Disease with Abdominal Distension
Published on: September 1, 2023
相关概念视频
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
